Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sheppard

Showing results (41-50 of 397) with videos related to

Pageof 40
Sort By:
Eye & Contact Lens|October 11, 2024
Impact of Neurostimulation, Immunomodulation, Topical Medication Application, and Surgical Reconstruction on Corneal Nerve Function and RegenerationTaylor N Drake, John D Sheppard
Journal of Ocular Pharmacology|January 1, 1986
Oral haloperidol lowers human intraocular pressureJ D Sheppard, D J Schaid
Biotechnology and Bioengineering|August 20, 1990
Development of computerized feedback control for the continuous phasing of Bacillus subtilisJ D Sheppard, D G Cooper
British Medical Journal|August 27, 2010
Torsion of Pedunculated Gastric CystM D Sheppard, J R Gilmour
The New Zealand Medical Journal|December 1, 1970
Vitamin E and selenium in cows' milkK R Millar, A D Sheppard
Methods in Enzymology|January 1, 1993
Two-dimensional gel analysis of repetitive DNA familiesR D Sheppard, L M Silver
Clinical Ophthalmology (Auckland, N.Z.)|August 15, 2019
Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgeryJ D Sheppard, I P Singh
Expert Opinion on Pharmacotherapy|February 13, 2018
Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroidTimothy L Comstock, John D Sheppard
Expert Opinion on Biological Therapy|December 2, 2005
Omalizumab: a future innovation for treatment of severe ocular allergy?Patricia B Williams, John D Sheppard
Leukemia Research|November 26, 1999
Mutational analysis of transgenic mouse B cell lymphomas: indication of a Trp53-independent pathway in tumor progressionS A Samant, R D Sheppard
Pageof 40

Showing results (41-50 of 397) with videos related to

Sort By:
Pageof 40
Eye & Contact Lens|October 11, 2024
Impact of Neurostimulation, Immunomodulation, Topical Medication Application, and Surgical Reconstruction on Corneal Nerve Function and RegenerationTaylor N Drake, John D Sheppard
Journal of Ocular Pharmacology|January 1, 1986
Oral haloperidol lowers human intraocular pressureJ D Sheppard, D J Schaid
Biotechnology and Bioengineering|August 20, 1990
Development of computerized feedback control for the continuous phasing of Bacillus subtilisJ D Sheppard, D G Cooper
British Medical Journal|August 27, 2010
Torsion of Pedunculated Gastric CystM D Sheppard, J R Gilmour
The New Zealand Medical Journal|December 1, 1970
Vitamin E and selenium in cows' milkK R Millar, A D Sheppard
Methods in Enzymology|January 1, 1993
Two-dimensional gel analysis of repetitive DNA familiesR D Sheppard, L M Silver
Clinical Ophthalmology (Auckland, N.Z.)|August 15, 2019
Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgeryJ D Sheppard, I P Singh
Expert Opinion on Pharmacotherapy|February 13, 2018
Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroidTimothy L Comstock, John D Sheppard
Expert Opinion on Biological Therapy|December 2, 2005
Omalizumab: a future innovation for treatment of severe ocular allergy?Patricia B Williams, John D Sheppard
Leukemia Research|November 26, 1999
Mutational analysis of transgenic mouse B cell lymphomas: indication of a Trp53-independent pathway in tumor progressionS A Samant, R D Sheppard
Pageof 40